Results for modified Karolinska questionnaire (KQ) and the Nottingham health profile (NHP) for both groups (Med, medical group; HBA, ablation group) at baseline line and all follow ups
| Baseline | 1 month | 3 months | 6 months | 12 months | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Med (n=18) | HBA (n=18) | Med (n=18) | HBA (n=18) | Med (n=18) | HBA (n=18) | Med (n=16) | HBA (n=18) | Med (n=16) | HBA (n=16) | ||||||||||
| KQ total score (0–140) | 50 (22) | 48 (26) | 18 (13)3-150 | 25 (24)3-150 | 26 (18)3-150 | 25 (18)3-150 | 26 (18)3-150 | 23 (20)3-150 | 22 (17)3-150 | 20 (18)3-150 | |||||||||
| Chest pain (0–40) | 9.5 (9.5) | 5.6 (6.7) | 4.5 (5.1)3-150 | 4.1 (5.3) | 6.1 (7.3)3-150 | 2.9 (4.7) | 6.0 (7.2)3-150 | 3.5 (4.9) | 4.7 (5.0)3-150 | 2.9 (4.3) | |||||||||
| Palpitations (0–30) | 13.3 (7.7) | 13.6 (9.0) | 2.4 (3.2)3-150 | 4.4 (6.3)3-150 | 3.8 (3.3)3-150 | 2.6 (3.2)3-150 | 4.1 (4.1)3-150 | 2.8 (3.6)3-150 | 4.5 (4.6)3-150 | 2.1 (2.5)3-150 | |||||||||
| Dizziness (0–20) | 8.1 (6.2) | 6.6 (6.8) | 1.8 (2.3)3-150 | 3.4 (5.8)3-150 | 3.1 (3.1)3-150 | 4.2 (5.2) | 4.3 (3.8)3-150 | 3.6 (4.7) | 1.9 (2.5)3-150 | 4.0 (4.9) | |||||||||
| Shortness of breath (0–30) | 12.4 (5.8) | 13.5 (7.9) | 4.6 (4.0)3-150 | 6.3 (6.6)3-150 | 7.8 (5.5)3-150 | 8.9 (6.9)3-150 | 6.9 (5.0)3-150 | 7.0 (7.2)3-150 | 6.7 (5.2)3-150 | 6.0 (5.2)3-150 | |||||||||
| General health (0–10) | 3.3 (2.6) | 3.9 (3.2) | 2.0 (1.8) | 2.8 (2.7)3-150 | 2.5 (2.0) | 2.6 (1.8) | 2.1 (2.0) | 2.5 (2.2) | 1.4 (1.2)3-150 | 2.0 (2.0)3-150 | |||||||||
| Activity (0–10) | 3.7 (3.0) | 4.6 (3.2) | 2.3 (1.5) | 4.4 (3.3) | 3.0 (1.9) | 3.3 (2.3) | 2.9 (2.5) | 3.4 (2.7) | 2.5 (2.2)3-150 | 3.2 (2.9)3-150 | |||||||||
| NHP total score (0–600) | 120 (90) | 145 (99) | 61 (80)3-150 | 105 (140)3-150 | 57 (64)3-150 | 118 (133)3-150 | 60 (65)3-150 | 109 (134)3-150 | 52 (63)3-150 | 80 (116)3-150 | |||||||||
| Physical mobility (0–100) | 22 (17) | 29 (21) | 8 (14)3-150 | 15 (22)3-150 | 7 (12)3-150 | 18 (20)3-150 | 8 (13)3-150 | 18 (20)3-150 | 9 (17)3-150 | 12 (13)3-150 | |||||||||
| Pain (0–100) | 14.3 (21) | 6.9 (11) | 6.5 (15)3-150 | 5.8 (19) | 4.8 (9)3-150 | 11 (22) | 8.3 (15)3-150 | 5.9 (11) | 5.0 (13)3-150 | 4.0 (7.5) | |||||||||
| Sleep (0–100) | 21 (22) | 34 (32) | 17 (28) | 29 (35) | 20 (29) | 30 (31) | 17 (24) | 29 (35) | 12 (22) | 25 (31) | |||||||||
| Energy (0–100) | 39 (38) | 44 (41) | 17 (28)3-150 | 35 (42) | 16 (32)3-150 | 34 (41) | 18 (25)3-150 | 28 (34) | 21 (25) | 22 (35) | |||||||||
| Social isolation (0–100) | 4.8 (10) | 9.4 (15) | 4.8 (16) | 5.6 (23) | 2.3 (7) | 10 (25) | 3.7 (11) | 10 (25) | 3.0 (10) | 7.0 (26) | |||||||||
| Emotional reaction (0–100) | 19 (22) | 22 (23) | 8.8 (17)3-150 | 15 (27) | 6.9 (13)3-150 | 15 (28) | 8.5 (15)3-150 | 19 (30) | 3.1 (7.3)3-150 | 13 (28) | |||||||||
A higher score means worse symptoms.
↵3-150 p < 0.05 for intra-group comparison with baseline measurements. There was no significant difference in the results for inter-group comparison of Med v HBA at all follow ups.